| Date Filed | Type | Description |
| 06/16/2023 |
4
| Curnutte John T (Director) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 105,000 options to buy
@ $0.495, valued at
$52k
|
|
| 06/08/2023 |
4
| Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/21/2022 |
4
| Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $6.8, valued at
$102k
|
|
| 06/08/2022 |
4
| Curnutte John T (Director) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 46,000 options to buy
@ $0.4747, valued at
$21.8k
|
|
| 06/30/2021 |
4
| Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 13,286 options to buy
@ $28.2, valued at
$374.7k
|
|
| 06/17/2021 |
4
| Curnutte John T (Director) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 40,000 options to buy
@ $4.79, valued at
$191.6k
|
|
| 06/19/2020 |
4
| Curnutte John T (Director) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 35,000 options to buy
@ $7.81, valued at
$273.4k
|
|
| 06/02/2020 |
3
| Curnutte John T (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
| 01/02/2020 |
3
| Curnutte John T (Director) has filed a Form 3 on Orchard Therapeutics plc |
| 05/21/2019 |
4
| Curnutte John T (EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 4,688 shares
@ $0
Granted 1,750 shares
@ $0
Paid exercise price by delivering 2,418 shares
@ $28.69, valued at
$69.4k
Paid exercise price by delivering 903 shares
@ $28.69, valued at
$25.9k
Exercised 4,688 rights
@ $0 |
|
| 03/05/2019 |
4
| Curnutte John T (EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 6,446 shares
@ $33.41, valued at
$215.4k
|
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2019 |
4
| Curnutte John T (EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 1,750 shares
@ $0
Paid exercise price by delivering 715 shares
@ $24.25, valued at
$17.3k
|
|
| 09/05/2018 |
4
| Curnutte John T (Interim Co-President & EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Exercised 17,500 shares
@ $0
Paid exercise price by delivering 8,884 shares
@ $29.1764, valued at
$259.2k
|
|
| 08/28/2018 |
4
| Curnutte John T (Interim Co-President & EVP R&D) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Exercised 17,500 shares
@ $0
Paid exercise price by delivering 8,171 shares
@ $26.05, valued at
$212.9k
|
|
| 05/24/2018 |
4
| Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 4,687 shares
@ $0
Paid exercise price by delivering 1,647 shares
@ $40.82, valued at
$67.2k
|
|
| 03/14/2018 |
4
| Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Exercised 5,049 options to buy
@ $8.5, valued at
$42.9k
|
|
| 03/06/2018 |
4
| Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 4,530 shares
@ $32.53, valued at
$147.4k
|
|
| 02/02/2018 |
4
| Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 8,750 shares
@ $0
Granted 35,000 options to buy
@ $51.31, valued at
$1.8M
|
|
| 09/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2017 |
4
| Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Granted 12,500 shares
@ $0
Granted 50,000 options to buy
@ $25.54, valued at
$1.3M
Granted 12,500 rights
@ $0 |
|
| 05/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2016 |
4
| Curnutte John T (Executive Vice President) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,271 shares
@ $31.75, valued at
$40.4k
|
|